December 21, 2020 by admin 0 Comments

ROKIT Healthcare Organ Regeneration Clinical Trials

  • ROKIT completed DFU clinical trials in Korea and India. Results from these studies showed 100% wound healing for all tested patients with chronic diabetic foot ulcers. Data from these studies have been analyzed and submitted for publication at SCI journals targeting a release by the end of this year.

  • Clinical study at DFU Lewis Gale Medical Center, Virginia, USA: study start date of December 2020. Dr. David G. Armstrong is the PI on this study evaluating the efficiency of autologous minimally manipulated homologous adipose tissue (AMHAT) in improving DFU. Dr. Armstrong is a worldrenowned podiatric surgeon, professor of surgery and Director at Keck School of Medicine of University of Southern California (USC), and a co-founder and director of the international diabetic foot conference, DFCon.

  • Clinical study at Ankara City Hospital, Turkey: study start date of November 2020. Dr. Ahmet Cinar Yasti is the PI on this study investigating DFURegen treatment. Dr. Yasti is a General Secretary of the Turkish Surgeon Society and Director of the Burn/Wound Center at Ankara City Hospital.

  • 1st human case of Cartilage Regeneration treatment using Dr. INVIVO 4D bioprinting technology took place on November 24 in Egypt: Cartilage Regeneration Platform is a therapeutic solution for osteoarthritis. By adopting our most cutting-edge technology, Dr. INVIVO 4D bioprinting, we aim to fully regenerate damaged cartilage tissue from arthritis ulcers. From the collaborative pre-clinical trial project with Mass General Hospital, we have already collected promising efficacy results. ROKIT will verify and validate the procedure in clinical scale at Assiut University Hospital in Egypt.

  • On November 23rd, ROKIT began a large pre-clinical animal model trial for HumaTein SKIN SPRAY. HumaTein SKIN-SPRAY is specially developed for treating soldiers with traumatic burn injuries in the field. HumaTein SKIN-SPRAY uses HumaTein technology that not only prevents infection as a first aid but also induces simultaneous skin regeneration that could dramatically reduce scar formation and hospitalization length to enhance patients’ quality of life.